Loading...

Stemmer Imaging

XTRA:S9I
Snowflake Description

Excellent balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
S9I
XTRA
€201M
Market Cap
  1. Home
  2. DE
  3. Tech
Company description

Stemmer Imaging AG provides machine vision technology for industry and science worldwide. The last earnings update was 29 days ago. More info.


Add to Portfolio Compare Print
S9I Share Price and Events
7 Day Returns
-4.3%
XTRA:S9I
1.6%
DE Electronic
0.8%
DE Market
1 Year Returns
-10.5%
XTRA:S9I
2.7%
DE Electronic
-4.5%
DE Market
S9I Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Stemmer Imaging (S9I) -4.3% 19.2% -12.3% -10.5% - -
DE Electronic 1.6% 10.5% 19.9% 2.7% 97.7% 106%
DE Market 0.8% 6.9% 8.1% -4.5% 10.4% 13.9%
1 Year Return vs Industry and Market
  • S9I underperformed the Electronic industry which returned 2.7% over the past year.
  • S9I underperformed the Market in Germany which returned -4.5% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Stemmer Imaging undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Stemmer Imaging to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Stemmer Imaging.

XTRA:S9I Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for XTRA:S9I
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Electronic Unlevered Beta Simply Wall St/ S&P Global 1.07
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.068 (1 + (1- 30%) (0.06%))
1.046
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.05
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.046 * 5.96%)
6.46%

Discounted Cash Flow Calculation for XTRA:S9I using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Stemmer Imaging is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

XTRA:S9I DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 6.46%)
2019 5.40 Analyst x2 5.07
2020 8.20 Analyst x2 7.23
2021 10.15 Analyst x2 8.41
2022 11.67 Est @ 14.96% 9.08
2023 12.90 Est @ 10.54% 9.43
2024 13.86 Est @ 7.44% 9.52
2025 14.59 Est @ 5.28% 9.41
2026 15.14 Est @ 3.76% 9.17
2027 15.55 Est @ 2.7% 8.85
2028 15.85 Est @ 1.96% 8.47
Present value of next 10 years cash flows €84.66
XTRA:S9I DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €15.85 × (1 + 0.23%) ÷ (6.46% – 0.23%)
€254.84
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €254.84 ÷ (1 + 6.46%)10
€136.24
XTRA:S9I Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €84.66 + €136.24
€220.89
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €220.89 / 6.50
€33.98
XTRA:S9I Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in XTRA:S9I represents 0.99676x of DB:S9I
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99676x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 33.98 x 0.99676
€33.87
Value per share (EUR) From above. €33.87
Current discount Discount to share price of €30.80
= -1 x (€30.80 - €33.87) / €33.87
9.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Stemmer Imaging is available for.
Intrinsic value
9%
Share price is €30.8 vs Future cash flow value of €33.87
Current Discount Checks
For Stemmer Imaging to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Stemmer Imaging's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Stemmer Imaging's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Stemmer Imaging's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Stemmer Imaging's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
XTRA:S9I PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €0.32
DB:S9I Share Price ** DB (2019-04-25) in EUR €30.9
Germany Electronic Industry PE Ratio Median Figure of 13 Publicly-Listed Electronic Companies 23.82x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 20.1x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Stemmer Imaging.

XTRA:S9I PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= DB:S9I Share Price ÷ EPS (both in EUR)

= 30.9 ÷ 0.32

96.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Stemmer Imaging is overvalued based on earnings compared to the DE Electronic industry average.
  • Stemmer Imaging is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Stemmer Imaging's expected growth come at a high price?
Raw Data
XTRA:S9I PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 96.34x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
45.9%per year
Germany Electronic Industry PEG Ratio Median Figure of 12 Publicly-Listed Electronic Companies 2.18x
Germany Market PEG Ratio Median Figure of 268 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

XTRA:S9I PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 96.34x ÷ 45.9%

2.1x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Stemmer Imaging is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Stemmer Imaging's assets?
Raw Data
XTRA:S9I PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €10.59
DB:S9I Share Price * DB (2019-04-25) in EUR €30.9
Germany Electronic Industry PB Ratio Median Figure of 19 Publicly-Listed Electronic Companies 2.57x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.87x
XTRA:S9I PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= DB:S9I Share Price ÷ Book Value per Share (both in EUR)

= 30.9 ÷ 10.59

2.92x

* Primary Listing of Stemmer Imaging.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Stemmer Imaging is overvalued based on assets compared to the DE Electronic industry average.
X
Value checks
We assess Stemmer Imaging's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Electronic industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Electronic industry average (and greater than 0)? (1 check)
  5. Stemmer Imaging has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Stemmer Imaging expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
45.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Stemmer Imaging expected to grow at an attractive rate?
  • Stemmer Imaging's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Stemmer Imaging's earnings growth is expected to exceed the Germany market average.
  • Stemmer Imaging's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
XTRA:S9I Future Growth Rates Data Sources
Data Point Source Value (per year)
XTRA:S9I Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 45.9%
XTRA:S9I Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 13.1%
Germany Electronic Industry Earnings Growth Rate Market Cap Weighted Average 12.9%
Germany Electronic Industry Revenue Growth Rate Market Cap Weighted Average 7.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
XTRA:S9I Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
XTRA:S9I Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-06-30 188 1
2022-06-30 169 1
2021-06-30 148 12 13 3
2020-06-30 132 10 11 3
2019-06-30 112 7 7 3
XTRA:S9I Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 104 3 2
2018-09-30 102 3
2018-06-30 101 3 3
2018-03-31 98 2
2017-12-31 94 8 4
2017-09-30 90 3
2017-06-30 88 5 3
2016-06-30 84 5 2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Stemmer Imaging's earnings are expected to grow significantly at over 20% yearly.
  • Stemmer Imaging's revenue is expected to grow by 13.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
XTRA:S9I Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Stemmer Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:S9I Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-06-30
2022-06-30
2021-06-30 1.98 1.99 1.97 2.00
2020-06-30 1.64 1.68 1.59 2.00
2019-06-30 0.94 1.18 0.67 3.00
XTRA:S9I Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 0.32
2018-09-30
2018-06-30 0.45
2018-03-31
2017-12-31 0.57
2017-09-30 0.61
2017-06-30
2016-06-30

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Stemmer Imaging is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Stemmer Imaging's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Stemmer Imaging has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Stemmer Imaging performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Stemmer Imaging's growth in the last year to its industry (Electronic).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Stemmer Imaging's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Stemmer Imaging's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Stemmer Imaging's 1-year earnings growth is negative, it can't be compared to the DE Electronic industry average.
Earnings and Revenue History
Stemmer Imaging's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Stemmer Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:S9I Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 103.98 2.09
2018-09-30 102.20 3.32
2018-06-30 100.63 2.94
2018-03-31 98.39 1.93 19.58
2017-12-31 93.61 3.71
2017-09-30 89.66 3.04 19.89
2017-06-30 88.30 2.80
2016-06-30 83.60 2.18 16.58
2015-06-30 75.73 1.81 14.97
2014-06-30 64.98 2.86 12.26

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Stemmer Imaging has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Stemmer Imaging used its assets less efficiently than the DE Electronic industry average last year based on Return on Assets.
  • Stemmer Imaging's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Stemmer Imaging's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Electronic industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Stemmer Imaging has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Stemmer Imaging's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Stemmer Imaging's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Stemmer Imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Stemmer Imaging's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Stemmer Imaging's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 655.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Stemmer Imaging Company Filings, last reported 3 months ago.

XTRA:S9I Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 69.05 0.11 47.66
2018-09-30 69.72 0.00 54.72
2018-06-30 68.44 0.00 51.76
2018-03-31 67.77 0.00 49.79
2017-12-31 17.08 0.00 7.09
2017-09-30 15.94 0.00 5.69
2017-06-30 14.62 0.00 5.51
2016-06-30 24.97 0.00 13.35
2015-06-30 23.31 0.00 10.34
2014-06-30 20.59 0.08 11.90
  • Stemmer Imaging's level of debt (0.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Stemmer Imaging's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (2927.9%, greater than 20% of total debt).
  • Stemmer Imaging earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess Stemmer Imaging's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Stemmer Imaging has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Stemmer Imaging's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.62%
Current annual income from Stemmer Imaging dividends. Estimated to be 1.62% next year.
If you bought €2,000 of Stemmer Imaging shares you are expected to receive €32 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Stemmer Imaging's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.44%).
  • Stemmer Imaging's dividend is below the markets top 25% of dividend payers in Germany (3.67%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
XTRA:S9I Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
Germany Electronic Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.1%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

XTRA:S9I Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2023-06-30
2022-06-30
2021-06-30 0.50 1.00
2020-06-30 0.50 1.00
2019-06-30 0.50 1.00
XTRA:S9I Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2018-09-28 0.500 1.505

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Stemmer Imaging has stable dividend payments.
  • Stemmer Imaging only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Stemmer Imaging's earnings are paid to the shareholders as a dividend.
  • Dividends paid are not well covered by earnings (0.6x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.6x coverage).
X
Income/ dividend checks
We assess Stemmer Imaging's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Stemmer Imaging afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Stemmer Imaging has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Stemmer Imaging's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Arne Dehn
AGE 49
TENURE AS CEO 0.2 years
CEO Bio

Mr. Arne E. Dehn has been the Chief Executive Officer of Stemmer Imaging AG since February 28, 2019 and has been its Member of Executive Board since January 1, 2019. Mr. Dehn served as a Member of the Executive Board of TKH Group NV from August 1, 2011 to May 3, 2018. Mr. Dehn was responsible for the business segment Building Solutions within TKH Group. Mr. Dehn has a German nationality and has ample international management experience, with companies such as Honeywell Automation Controls Business, where he has been in charge of ESSER & Ackermann in Germany.

CEO Compensation
  • Insufficient data for Arne to compare compensation growth.
  • Insufficient data for Arne to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team

Arne Dehn

TITLE
CEO & Member of Executive Board
AGE
49
TENURE
0.2 yrs

Lars Böhrnsen

TITLE
CFO & Member of Management Board
AGE
43
TENURE
1.4 yrs

Martin Kersting

TITLE
Chief Technical Officer & Member of Management Board

Mark Williamson

TITLE
MD & Director of Corporate Market Development

David Hearn

TITLE
Managing Director of United Kingdom Operations

Claudio Sager

TITLE
Managing Director of Switzerland Operations

Dietmar Serbée

TITLE
Managing Director - Benelux
Board of Directors

Klaus Weinmann

TITLE
Chairman of the Supervisory Board

Markus Saller

TITLE
Member of Supervisory Board

Stefan Kober

TITLE
Member of Supervisory Board
AGE
48
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Stemmer Imaging's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Stemmer Imaging has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Stemmer Imaging AG provides machine vision technology for industry and science worldwide. The company offers machine vision systems, such as 2D and 3D smart vision, chemical color imaging hyperspectral, surface inspection, open architecture vision, and sequence recording systems; illumination products, including LED illumination products, diode lasers, cold light sources and high-frequency illumination products, and accessories for illumination; and optics consisting of zoom, fixed focus, general purpose, telecentric measuring, macro and system, semi-automatic and motorized, and other lenses, as well as accessories for lenses. It also provides cameras, including area and line scan, 3D, smart, high speed recording, and spectral cameras, as well as contact image sensors and ID readers, and accessories for cameras; CameraLink, GigE, CoaXPress, USB, FireWire, fibre optic, and analogue cables; CameraLink, CameraLink HS-Link, CoaXPress, GigE, DVI, LVDS, analogue, and FireWire input products, as well as accessories for image acquisition, and IP streaming and video decoders/encoders; computers, such as industrial and compact PC systems; accessories for systems, lenses, cameras, and image acquisition, as well as illumination accessories; and various machine vision software products. Further, the company provides solutions-oriented advisory, feasibility study, customized cabling, individual hardware and software development, training, pre-delivery component testing, and support and repair services, as well as loans. It serves the automotive, defense, security and aerospace, electronics, semiconductor and solar, factory automation, food and beverage, medical imaging, pharmaceutical, print and packaging, scientific research, sports, entertainment and broadcast, test and measurement, traffic, and rail and transport markets. The company was founded in 1987 and is headquartered in Puchheim, Germany. Stemmer Imaging AG is a subsidiary of AL-KO Kober SE.

Details
Name: Stemmer Imaging AG
S9I
Exchange: XTRA
Founded: 1987
€200,850,000
6,500,000
Website: http://www.stemmer-imaging.com/de-de
Address: Stemmer Imaging AG
Gutenbergstrasse 9-13,
Puchheim,
Bavaria, 82178,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
DB S9I Bearer Ordinary Shares Deutsche Boerse AG DE EUR 22. Feb 2018
XTRA S9I Bearer Ordinary Shares XETRA Trading Platform DE EUR 22. Feb 2018
LSE 0OC9 Bearer Ordinary Shares London Stock Exchange GB EUR 22. Feb 2018
Number of employees
Current staff
Staff numbers
290
Stemmer Imaging employees.
Industry
Electronic Equipment and Instruments
Tech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/25 23:18
End of day share price update: 2019/04/25 00:00
Last estimates confirmation: 2019/04/02
Last earnings filing: 2019/03/27
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.